Surgical anti-adhesive starts pilot trials:
This article was originally published in Clinica
Executive Summary
Gliatech, of Cleveland, Ohio, plans to begin pilot FDA approved trials in humans of its ADCON-A anti-adhesion product ADCON-A is a resorbable, carbohydrate polymer liquid that covers the upper peritoneal cavity and is designed to prevent scarring and adhesions following certain abdominal and colorectal surgeries. The company is developing a range of surgical anti-adhesion products based on the ADCON platform but only one, ADCON-L, for lumbar surgery, is available in the US.